文献速递临床试验与 GCP流行病学与生物统计

创伤患者的叹气通气:SiVent随机临床试验

Sigh Ventilation in Patients With Trauma: The SiVent Randomized Clinical Trial.
PubMed 文献 · JAMA · 2023-01-01

这项实用随机试验在美国15家学术创伤中心纳入524例接受机械通气且有急性呼吸窘迫综合征风险的创伤患者,比较叹气通气加常规治疗与单纯常规治疗。主要结局无创通气天数差异未达统计学显著(中位数18.4 vs 16.1,P=0.08;校正后平均差1.4天,95%CI -0.2至3.0)。预设次要结局28天死亡率叹气组11.6% vs 常规组17.6%(P=0.05),非致命不良事件两组相近。

要点

  • 叹气通气未显著增加无创通气天数(中位数18.4 vs 16.1,P=0.08)。
  • 28天死亡率叹气组11.6%(30/259)vs 常规组17.6%(46/261),P=0.05。
  • 非致命不良事件叹气组30.9%(80/259)vs 常规组30.7%(80/261)。

核心结论

  • 在因创伤接受机械通气且存在急性呼吸窘迫综合征风险因素的患者中,加用叹气通气未显著增加无创通气天数,预设次要结局数据提示叹气通气耐受良好并可能改善临床结局。

研究设计与样本

  • 实用随机临床试验,2016年至2022年在美国15家学术创伤中心开展,随访28天,共筛查5753例、纳入524例(平均[SD]年龄43.9[19.2]岁,394例[75.2%]为男性)。

主要发现

  • 无创通气天数中位数叹气组18.4天(IQR 7.0-25.2)vs 常规治疗组16.1天(IQR 1.1-24.4),P=0.08。
  • 无创通气天数未校正平均差为1.9天(95%CI 0.1至3.6),预设校正平均差为1.4天(95%CI -0.2至3.0)。
  • 28天死亡率叹气组11.6%(30/259)vs 常规治疗组17.6%(46/261),P=0.05。
  • 非致命不良事件叹气组80/259(30.9%)vs 常规治疗组80/261(30.7%),未见差异。

局限性

  • 主要结局无创通气天数差异未达统计学显著(P=0.08),预设校正平均差95%CI为-0.2至3.0。
  • 预设次要结局28天死亡率P=0.05,原文结论称该数据仅提示叹气通气可能改善临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Among patients receiving mechanical ventilation, tidal volumes with each breath are often constant or similar. This may lead to ventilator-induced lung injury by altering or depleting surfactant. The role of sigh breaths in reducing ventilator-induced lung injury among trauma patients at risk of poor outcomes is unknown. OBJECTIVE: To determine whether adding sigh breaths improves clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS: A pragmatic, randomized trial of sigh breaths plus usual care conducted from 2016 to 2022 with 28-day follow-up in 15 academic trauma centers in the US. Inclusion criteria were age older than 18 years, mechanical ventilation because of trauma for less than 24 hours, 1 or more of 5 risk factors for developing acute respiratory distress syndrome, expected duration of ventilation longer than 24 hours, and predicted survival longer than 48 hours. INTERVENTIONS: Sigh volumes producing plateau pressures of 35 cm H2O (or 40 cm H2O for inpatients with body mass indexes >35) delivered once every 6 minutes. Usual care was defined as the patient's physician(s) treating the patient as they wished. MAIN OUTCOMES AND MEASURES: The primary outcome was ventilator-free days. Prespecified secondary outcomes included all-cause 28-day mortality. RESULTS: Of 5753 patients screened, 524 were enrolled (mean [SD] age, 43.9 [19.2] years; 394 [75.2%] were male). The median ventilator-free days was 18.4 (IQR, 7.0-25.2) in patients randomized to sighs and 16.1 (IQR, 1.1-24.4) in those receiving usual care alone (P = .08). The unadjusted mean difference in ventilator-free days between groups was 1.9 days (95% CI, 0.1 to 3.6) and the prespecified adjusted mean difference was 1.4 days (95% CI, -0.2 to 3.0). For the prespecified secondary outcome, patients randomized to sighs had 28-day mortality of 11.6% (30/259) vs 17.6% (46/261) in those receiving usual care (P = .05). No differences were observed in nonfatal adverse events comparing patients with sighs (80/259 [30.9%]) vs those without (80/261 [30.7%]). CONCLUSIONS AND RELEVANCE: In a pragmatic, randomized trial among trauma patients receiving mechanical ventilation with risk factors for developing acute respiratory distress syndrome, the addition of sigh breaths did not significantly increase ventilator-free days. Prespecified secondary outcome data suggest that sighs are well-tolerated and may improve clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02582957.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Albert RK, Jurkovich GJ, Connett J, et al. Sigh Ventilation in Patients With Trauma: The SiVent Randomized Clinical Trial. JAMA. 2023. PMID: 37877609. doi:10.1001/jama.2023.21739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。